• Explore /
  • Poster
  • / A phase II study of AK112 (PD-1/VEGF bispecific) in combination with chemotherapy in patients with advanced non-small cell lung cancer.

A phase II study of AK112 (PD-1/VEGF bispecific) in combination with chemotherapy in patients with advanced non-small cell lung cancer.

Abstract Poster

Authors

null

Yuangyuan Zhao

Sun Yat-sen University Cancer Center, Guangzhou, China

Yuangyuan Zhao , Wenfeng Fang , Yunpeng Yang , Jianhua Chen , Li Zhuang , Yingying Du , Qitao Yu , Yanqiu Zhao , Wu Zhuang , Ming Zhou , Weidong Zhang , Yu Zhang , Yixin Wan , Ziping Wang , Lin Wang , Yu Xia , Baiyong Li , Zhongmin Maxwell Wang , Weifeng Song , Li Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04736823

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9019)

DOI

10.1200/JCO.2022.40.16_suppl.9019

Abstract #

9019

Poster Bd #

7

Abstract Disclosures

Similar Posters

First Author: Atsushi Nakamura

First Author: Vassiliki Papadimitrakopoulou

First Author: Harry J.M. Groen

First Author: Sehhoon Park